| Literature DB >> 32617213 |
Nicola Serra1, Claudia Colomba2, Paola Di Carlo2,3, Gabriele Palermo2, Teresa Fasciana4, Anna Giammanco2, Giuseppina Novo2, Teresa Rea5, Maria Michela Marino6, Vincenzo Argano7, Consolato Sergi8.
Abstract
Background Infective endocarditis (IE) is an uncommon disease with an involved interplay of clinical and surgical team management. We aimed to define diagnosis parameters and delineate in-hospital management in patients with IE admitted in a tertiary hospital of Southern Italian. Materials and methods Fifty-six consecutive patients (42 males, 14 females; age range: 34-85 years) admitted for IE in the Infectious Diseases, Cardiac Surgery, and Cardiology units, between January 2011 and August 2017, were enrolled. Demographic data, mortality, comorbidities, specimen type, microscopy results, special histological staining performed, and antimicrobial therapy were collected and analyzed. Any comments at the multidisciplinary team meetings were recorded in minutes of and approved. Results We found 83.9% of patients with positive blood cultures. The four most common bacteria were methicillin-resistant Staphylococcus aureus (MRSA: 21.3%), methicillin-sensitive Staphylococcus aureus (MSSA: 17%), Streptococci (14.9%), and Enterococci (14.9%). Both in the univariate and multivariate analysis, we observed a significant positive correlation between surgery and complications. Particularly in the univariate analysis only, surgery was positively correlated to males and C-reactive protein (CPR) at baseline. Also, considering the most common bacteria, it resulted in a positive correlation between surgery and MRSA and Streptococci spp. and between complications and MSSA. Finally, the male gender was positively correlated to MSSA and heart complications, major arterial embolism, septic pulmonary emboli, splenic infarction, and cerebral embolism. Conclusions A blood culture test remains a critical factor for the diagnosis of IE and the antibiotic treatment of susceptible and emerging resistant bacteria. Male gender and heart complications are red flags for prompt operative management.Entities:
Keywords: adult cardiac surgery; candida endocarditis; complications; endocarditis; gender; matlab; microorganisms; multi-drug resistant bacteria; multivariate analysis; univariate analysis
Year: 2020 PMID: 32617213 PMCID: PMC7325401 DOI: 10.7759/cureus.8338
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographics, clinical characteristics, and complications of 56 patients with infective endocarditis
Minor embolic phenomena: Roth spot, Osler node; immunologic phenomena = glomerulonephritis; §Musculoskeletal manifestations = arthralgias, arthritis, and diffuse myalgia; TTE = transthoracic echocardiography; # T0 = within the first week from hospital admission; complications = major embolic phenomena and patients with clinical heart failure and echocardiogram manifestations other than vegetation; *heart complications = patients with clinical heart failure and echocardiogram manifestations other than vegetation
| Variables | Value or percentage |
| Age years (mean ±SD) | 62.8±14.9 |
| Male | 75% (42/56) |
| Native valve | 73.2% (41/56) |
| Prosthetic Valve | 19.6% (11/56) |
| Cardiac implantable electronic devices (CIEDs) | 7.1% (4/56) |
| A history of endocarditis | 10.7% (6/56) |
| HIV | 12.5% (7/56) |
| Cancer | 7.1% (4/56) |
| Hemodialysis | 8.9% (5/56) |
| Hospital mortality rate | 37.5% (21/56) |
| Minor Criteria | |
| Fever (>38° C) | 87.5% (49/56) |
| Immunologic phenomena and minor embolic phenomena | 25.0% (14/56) |
| Musculoskeletal manifestations§ | 17.9% (10/56) |
| Intravenous drug users | 10.7% (6/56) |
| Congenital heart defects | 1.8% (1/56) |
| Predisposing heart condition or intravenous drug use | 1.8% (1/56) |
| Major diagnostic criteria | |
| TTE positive for IE at T0 | 87.5% (49/56) |
| TEE positive for IE | 58.9% (33/56) |
| Blood culture or serological evidence of active infection | 83.9% (47/56) |
| Complications # | 60.7% (34/56) |
| Heart complications * | 46.4% (26/56) |
| Arrhythmia and conduction disorders | 73.1% (19/26) |
| Clinical heart failure | 38.5% (10/26) |
| Abscess | 11.5% (3/26) |
| Prosthetic valve dehiscence | 11.5% (3/26) |
| Valve perforation | 7.7 % (2/26) |
| Myocarditis / Pericarditis | 3.8% (1/26) |
| Valve aneurysm | 3.8% (1/26) |
| Cerebral embolism | 21.4% (12/56) |
| Septic pulmonary emboli | 12.5% (7/56) |
| Major arterial embolism | 12.5% (7/56) |
| Splenic infarction | 10.7% (6/56) |
| Surgery | 28.6% (16/56) |
| Indication for surgery | 46.4% (26/56) |
| Persistent infection | 26.9% (7/26) |
| Heart failure | 38.5% (10/26) |
| Abscess | 11.5% (3/26) |
| Prosthetic valve dehiscence | 11.5% (3/26) |
| Valve perforation | 7.7% (2/26) |
| Valve aneurysm | 3.8% (1/26) |
Laboratory and microbiological isolates of 56 studied patients with infective endocarditis, 2011-2017
WBC = white blood cells; RBC = red blood cells; HB = hemoglobin; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein (normal values < 5 mg/dl); T0 = in the first three days of admission; MDR = multidrug resistant
| Laboratory parameters | % Patients |
| RBC low (< 4.0 x 106/µl) | 64.3% (36/56) |
| HB (≤10 g/dl) | 62.5% (35/56) |
| WBC (>11 x 103/µl) | 44.6% (25/56) |
| CRP at T0 (≥8 mg/l) | 83.9% (47/56) |
| ESR at T0 (≥20 mm/hour) | 46.4% (26/56) |
| Microorganisms identified in patients with positive (n=47) blood cultures. | % Patients |
| Blood culture negative endocarditis (BCNE) | 16.1% (9/56) |
| Methicillin-resistant Staphylococcus aureus (MRSA) | 21.3% (10/47) |
| Methicillin-sensitive Staphylococcus aureus (MSSA) | 17.0% (8/47) |
| Streptococcus spp. | 14.9% (7/47) |
| Vancomycine-susceptible Enterococcus spp. (VSE) | 10.6% (5/47) |
| Coagulase-negative Staphylococci (CoNS) | 8.5% (4/47) |
| Methicillin-resistant coagulase-negative Staphylococci resistant (MR-CoNS) | 8.5% (4/47) |
| MDR E. coli | 6.4% (3/47) |
| Vancomycin-resistant Enterococcus spp. (VRE) | 4.2% (2/47) |
| Brucella melitensis | 2.1% (1/47) |
| Candida albicans | 2.1% (1/47) |
| Neisseria elongata subsp. nitroreducens | 2.1% (1/47) |
| Propionibacterium acnes | 2.1% (1/47) |
Valves and infecting organisms in 56 enrolled patients
N.B.: Some patients had more than one valve involved.
CoNS = coagulase-negative Staphylococcus; MR-CoNS = resistant to methicillin coagulase-negative Staphylococcus; N.el. sub. Nitr. = Neisseria elongata subsp. nitroreducens; MRSA: methicillin-resistant Staphylococcus aureus; MSSA: methicillin-sensitive Staphylococcus aureus; VSE: vancomycin-susceptible Enterococcus faecalis; VRE: vancomycin-resistant Enterococcus app.; MDR: multidrug-resistant
| Microorganism | Mitral native valve (19 pts) | Aortic native valve (17 pts) | Tricuspid native valve (5 Pts) | Aortic prosthetic valve (5 pts) | Mitral prosthetic valve (6 pts) | Cardiac implantable electronic devices (4 pts) |
| CoNS | 5.9% (1/17) | 20% (1/5) | 20% (1/5) | 16.7% (1/6) | ||
| MRSA | 26.3% (5/19) | 17.6% (3/17) | 20% (1/5) | 16.7% (1/6) | ||
| MSSA | 10.5% (2/19) | 23.5% (4/17) | 40% (2/5) | |||
| MR-CoNS | 5.3% (1/19) | 5.9% (1/17) | 20% (1/5) | 20% (1/5) | ||
| VSE | 10.5% (2/19) | 5.9% (1/17) | 16.7% (1/6) | 14.3% (1/4) | ||
| VRE | 20% (1/5) | 14.3% (1/4) | ||||
| Streptococcus spp | 21.0% (4/19) | 5.9%(3/17) | ||||
| E. coli MDR | 33.3% (2/6) | 33.3% (1/4) | ||||
| Brucella melitensis | 5.9% (1/17) | |||||
| Candida albicans | 14.3% (1/4) | |||||
| Propionibacterium acnes | 16.7% (1/6) | |||||
| N.el. sub. Nitr. | 5.3% (1/19) |
Univariate and multivariate linear correlation analysis between surgery (dependence variable) and independence variables such as: age, gender, blood cultures, previous endocarditis, native valve, complications, WBC/RBC score, CPR at T0 and HIV+
* = significant test; R = Pearson’s linear correlation coefficient; R_partial = the partial correlation coefficient is the coefficient of correlation of the variable with the dependent variable, adjusted for the effect of the other variables in the mode; WBC = white blood cells; RBC = red blood cells; CRP = C-reactive protein (normal values < 5 mg/dl); T0 = within first week of admission; HIV: human immunodeficiency virus
| Linear correlation analysis | Univariate analysis R (p-value) | Multivariate analysis (Rpartial; p-value) |
| Multiple linear correlation coefficient = 0.797 | ||
| Surgery / Age | -0.106 (0.438) | Rpartial = -0.392; p-value = 0.0071 * |
| Surgery / Gender | -0.603 (<0.0001) * | Rpartial = 0.126.; p-value = 0.405 |
| Surgery / Blood Cultures | -0.225 (0.096) | Rpartial = 0.022; p-value = 0. 887 |
| Surgery / Previous endocarditis | 0.056 (0.684) | R partial = -0.128; p-value = 0.396 |
| Surgery / Native valve | -0.142 (0.307) | Rpartial = 0.053; p-value = 0.726 |
| Surgery / Complications | 0.603 (< 0.0001) * | Rpartial = 0.339; p-value = 0.0212 * |
| Surgery / CPR at T0 | 0.642 (< 0.0001) * | Rpartial = -0.031; p-value = 0.840 |
| Surgery / WBC/RBC score | 0.213 (0.116) | Rpartial = 0.071; p-value = 0.638 |
| Surgery / HIV infected | -0.616 (< 0.0001) * | Rpartial = -0.336; p-value = 0.0223 * |
Univariate and multivariate linear correlation analyses between surgery and complications (dependence variables) with independence variables such as MRSA, MSSA, Streptococci, VSE, CoNS, MR-CoNS, MDR E. coli, VRE, Candida albicans, Neisseria elongata subsp. nitroreducens, Brucella spp., and Propionibacterium acnes
* = significant test; R = Pearson’s linear correlation coefficient; R_partial = the partial correlation coefficient is the coefficient of correlation of the variable with the dependent variable, adjusted for the effect of the other variables in the mode; MRSA = methicillin-resistant Staphylococcus; MSSA = methicillin-sensitive Staphylococcus aureus; MR-CoNS = methicillin-resistant coagulase-negative Staphylococci resistant; VSE = vancomycin-susceptible Enterococcus spp; N el. Subsp. Nitr. = Neisseria elongata subsp. nitroreducens
| Linear correlation analysis | Univariate analysis R (p-value) | Multivariate analysis (Rpartial; p-value) |
| Multiple linear correlation coefficient = 0.983 | ||
| Complications / MRSA | -0.07 (0.608) | Rpartial = -0.741; p-value < 0.0001 * |
| Complications / MSSA | 0.54 (<0.0001) * | Rpartial = -0.555.; p-value = 0.0001 * |
| Complications / Streptococci | 0.01 (0.934) | Rpartial = -0.663; p-value < 0.0001 * |
| Complications / VSE | 0.04 (0.785) | Rpartial = -0.247; p-value = 0.103 |
| Complications / CoNS | -0.04 (0.759) | Rpartial = -0.261; p-value = 0.083 |
| Complications / MR-CoNS | 0.022 (0.873) | Rpartial = -0.894; p-value < 0.0001 * |
| Complications / MDR E.coli | 0.242 (0.072) | Rpartial = -0.339; p-value = 0.0229 * |
| Complications / VRE | 0.022 (0.872) | Rpartial = -0.456; p-value = 0.0016* |
| Complications / Brucella meliensis Brucella spp. | 0.339 (0.0106) * | Rpartial = -0.102; p-value = 0.505 |
| Complications / Candida albicans | -0.727 (< 0.0001) * | Rpartial = -0.910; p-value < 0.0001 * |
| Complications / Neisseria elongata subsp | 0.03 (0.856) | Rpartial = -0.115; p-value = 0.451 |
| Complications / Propionibacterium acnes | 0.024 (0.860) | Rpartial = -0.845; p-value < 0.0001 * |
| Multiple linear correlation coefficient = 0.921 | ||
| Surgery / MRSA | 0.287 (0.0323) * | Rpartial = -0.210; p-value = 0.167 |
| Surgery / MSSA | 0.004 (0.977) | Rpartial = -0.403; p-value = 0.006 * |
| Surgery / Streptococci | 0.394 (0.0027) * | Rpartial = -0.205; p-value = 0.177 |
| Surgery / VSE | 0.256 (0.057) | Rpartial = -0.03; p-value = 0.844 |
| Surgery / CoNS | 0.286 (0.0325) * | Rpartial = -0.176; p-value = 0.289 |
| Surgery / MR-CoNS | 0.034 (0.802) | Rpartial = -0.339; p-value = 0.0227 * |
| Surgery / MDR E.coli | -0.275 (0.0406) | Rpartial = -0.394; p-value = 0.0075 * |
| Surgery / VRE | 0.350 (0.0083) * | Rpartial = -0.04; p-value = 0.806 |
| Surgery / Brucella meliensis | 0.285 (0.0336) * | Rpartial = 0.60; p-value < 0.0001 * |
| Surgery / Candida albicans | -0.674 (< 0.0001) * | Rpartial = -0.576; p-value < 0.0001 * |
| Surgery / N el. Subsp. Nitr. | 0.10 (0.477) | Rpartial = 0.03; p-value = 0.869 |
| Surgery / Propioni bacterium acnes | -0.119 (0.385) | Rpartial = -0.519; p-value = 0.0003 * |
Univariate and multivariate linear correlation analysis between gender (dependence variable) with independence variables such as: MRSA, MSSA, Streptococci, VSE, CoNS, MR-CoNS, MDR E.coli, VRE, Candida albicans, Neisseria elongata subsp. Nitroreducens, Brucella spp., and Propionibacterium acnes; and gender with independence variables such as: heart complications, cerebral embolism septic, pulmonary emboli, major arterial embolism, and splenic infarction
Rpartial = -0.478; p-value = 0.0009 *
* = significant test; R = Pearson’s linear correlation coefficient; R_partial = the partial correlation coefficient is the coefficient of correlation of the variable with the dependent variable, adjusted for the effect of the other variables in the mode; MRSA = methicillin-resistant Staphylococcus; MSSA = methicillin-sensitive Staphylococcus aureus; MR-CoNS = methicillin-resistant coagulase-negative Staphylococci resistant; VSE = vancomycin-susceptible Enterococcus spp.; N. el. Subsp. Nitr. = Neisseria elongata subsp. nitroreducens
| Linear correlation analysis | Univariate analysis R (p-value) | Multivariate analysis (Rpartial; p-value) |
| Multiple linear correlation coefficient = 0.767 | ||
| Gender / Heart complications | -0.674 (<0.0001) * | Rpartial = -0.448; p-value = 0.0008 * |
| Gender / Cerebral embolism | -0.288 (0.0314) * | Rpartial = -0.174.; p-value = 0.219 |
| Gender / Septic pulmonary emboli | -0.416 (0.0014) * | Rpartial = -0.10; p-value = 0.497 |
| Gender / Major arterial embolism | -0.517 (<0.0001) * | R partial = -0.419; p-value = 0.0020 * |
| Gender / Splenic infarction | -0.372 ( 0.0048) * | Rpartial = -0.064; p-value = 0.653 |
| Multiple linear correlation coefficient = 0.987 | ||
| Gender / MRSA | 0.033 (0.807) | Rpartial = -0.001; p-value = 0.946 |
| Gender / MSSA | -0.422 (0.0012)* | Rpartial = -0.130; p-value = 0.394 |
| Gender / Streptococci | -0.114 (0.404) | Rpartial = -0.025; p-value = 0.872 |
| Gender / VSE | -0.321 (0.0159)* | Rpartial = -0.443; p-value = 0.0023 * |
| Gender / CoNS | -0.163 (0.231) | Rpartial = -0.11; p-value = 0.473 |
| Gender / MR-CoNS | -0.323 (0.0152)* | Rpartial = 0.129; p-value = 0.399 |
| Gender / MDR E.coli | -0.139 (0.308) | Rpartial = -0.559; p-value = 0.0001 * |
| Gender / VRE | -0.226 (0.094) | Rpartial = -0.202; p-value = 0.183 |
| Gender / Brucella meliensis | -0.251 (0.063) | Rpartial = -0.451; p-value = 0.0019 * |
| Gender / Candida albicans | 0.881 (< 0.0001) * | Rpartial = 0.787; p-value < 0.0001 * |
| Gender / N el. Subsp. Nitr. | -0.005 (0.971) | Rpartial = -0.162; p-value = 0.288 |
| Gender / Propioni bacterium acnes | -0.129 (0.345) |